You are here: Industry Insights > Glenmark

News List

Glenmark’s Ryaltris nasal spray gets approval in Europe for treatment of allergic rhinitis expresspharma
April 27, 2021
It is a novel fixed-dose combination nasal spray of an anti-histamine and a steroid, indicated for treatment of symptoms associated with allergic rhinitis (AR) in patients over 12 years of age.
Glenmark Pharma gets ANDA approval for chlorpromazine hydrochloride tablets expresspharma
March 25, 2021
Granted competitive generic therapy designation and is eligible for 180 days of CGT exclusivity.
Glenmark Pharma gets ANDA approval for diltiazem hydrochloride ER capsules expresspharma
March 24, 2021
Glenmark has been granted a competitive generic therapy (CGT) designation for Diltiazem hydrochloride extended release capsules USP, 60 mg, 90 mg, and 120 mg.
Glenmark gets USD 40 million COVID credit line from International Finance Corporation expresspharma
March 24, 2021
The loan to Glenmark will help it increase the availability of affordable, quality medicines in the country as well in other countries, including treatment for the pandemic.
Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada expresspharma
March 23, 2021
RYALTRIS is currently under review by Health Canada with a proposed indication for the treatment of seasonal allergic rhinitis in adults and children over 12 years of age.
Launch of generic oncology medications to improve treatment access in India europeanpharmaceuticalreview
March 04, 2021
GlobalData suggests the recent approval of new generics in oncology should enhance access and adherence to cancer treatment by reducing costs borne by patients.
Govt of India gives ‘India Pharma Innovation of the Year’ Award to Glenmark expresspharma
February 26, 2021
Glenmark Pharmaceuticals received the “India Pharma Innovation of the Year” Award, as part of the India Pharma & India Medical Device Awards 2021.
Glenmark gets USFDA approval for Clindamycin Phosphate Gel expresspharma
February 25, 2021
Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (US FDA) for Clindamycin Phosphate Gel USP, 1%, the generic version of Cleocin T Gel, 1%, of Pharmacia & Upjohn.
Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia expresspharma
February 22, 2021
Glenmark Pharmaceuticals announced that its Swiss subsidiary, Glenmark Specialty, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray – a fixed-dose combination nasal spray.
Glenmark launches SUTIB (Sunitinib) capsules in India to treat kidney cancer expresspharma
February 18, 2021
The company informs that the drug is priced 96 per cent lower than the innovator brand and reduces the risk of kidney cancer progression by 58 per cent.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page